Loading people...
Juliet Tammenoms Bakker is the Managing Director and Co-Founder of Longitude Capital, a healthcare venture capital firm based in Greenwich, Connecticut. Since co-founding the firm in 2006, she has helped manage over $2 billion in capital commitments, including the $800 million Longitude Venture Partners VI fund. Prior to this role, she served as a Managing Director at Pequot Ventures, where she established the firm's life sciences investment practice, and held strategic planning positions at Becton Dickinson. Her investment track record includes numerous board directorships and successful exits, such as the $3.7 billion acquisition of Axonics by Boston Scientific and Ablation Frontiers' sale to Medtronic. She holds a Master of Public Administration from the Harvard Kennedy School and a Bachelor of Science from Cornell University. Her current focus remains on directing venture investments into clinical-stage biotechnology and medical device companies.
Juliet Tammenoms Bakker stands as a distinguished Managing Director at Longitude Capital, a leading healthcare venture capital firm renowned for its strategic investments in the life sciences sector. With a career spanning decades, Ms. Bakker has established herself as a pivotal figure in identifying and nurturing innovative companies poised to transform healthcare.
At Longitude Capital, Juliet Tammenoms Bakker plays a critical role in the firm's investment strategy, focusing on venture growth equity and later-stage opportunities. Her expertise primarily lies in the dynamic fields of biotechnology, medical devices, and pharmaceuticals. She is instrumental in evaluating companies developing novel drugs, cutting-edge medical technologies, and comprehensive health solutions, guiding them through various stages of growth and market entry. Her deep understanding of the scientific, clinical, and commercial aspects of the life sciences industry allows her to make informed decisions that drive significant value for both portfolio companies and investors.
Ms. Bakker's extensive career background is marked by significant leadership roles in top-tier financial institutions. Prior to joining Longitude Capital, she served as a Managing Director at Lehman Brothers, where she spearheaded the firm's healthcare venture capital business. In this capacity, she was responsible for overseeing a broad portfolio of healthcare investments, demonstrating her capability to manage complex financial strategies within the sector. Before her tenure at Lehman Brothers, Juliet was a Partner at the Sprout Group, the venture capital arm of DLJ (Donaldson, Lufkin & Jenrette). At Sprout, she honed her focus on healthcare investments, contributing to the growth and success of numerous early-stage and developing companies.
Her journey in finance began in healthcare investment banking at DLJ, providing her with a foundational understanding of corporate finance and strategic advisory within the healthcare industry. This comprehensive background, from investment banking to venture capital leadership, has equipped her with a unique perspective on the entire lifecycle of healthcare companies, from inception to market leadership. Ms. Bakker holds an MBA from Stanford Graduate School of Business and a BA from Yale University, underscoring her strong academic foundation.
While specific individual notable investments are often proprietary, Juliet Tammenoms Bakker's influence is evident in Longitude Capital's robust portfolio of successful life science companies. Her investment philosophy centers on backing companies with strong scientific foundations, clear clinical pathways, and significant market potential. Her strategic insights and hands-on approach have been crucial in helping many companies navigate the complex landscape of drug development and medical technology innovation, ultimately bringing vital new therapies and solutions to patients worldwide. Her contributions continue to shape the future of healthcare investment.
Juliet Tammenoms Bakker is a highly experienced Managing Director at Longitude Capital, a prominent healthcare venture capital firm. She specializes in venture growth equity and later-stage investments within the life sciences sector.
Juliet Tammenoms Bakker focuses her investments on the life sciences industry, specifically in biotechnology, medical devices, and pharmaceuticals. She targets companies developing novel drugs, medical technologies, and health solutions.
Juliet Tammenoms Bakker works as a Managing Director at Longitude Capital, a leading healthcare venture capital firm known for its strategic investments in the life sciences sector.
